期刊文献+

Cx36在癫持续状态大鼠海马神经元的表达

Expression of connexin 36 in status epilepticus rat hippocampal neurons
下载PDF
导出
摘要 目的观察连接蛋白36(Cx36)在癫持续状态大鼠海马神经元的表达。方法建立36只氯化锂-匹罗卡品诱导的癫持续状态大鼠模型,随机分为生理盐水组、喹啉组、辛醇组(每组12只),分别予以腹腔注射生理盐水、喹啉、辛醇,通过Racine评分判断大鼠给药前后癫发作情况,利用免疫荧光染色法、Western-blot法检测各组大鼠海马Cx36的表达。结果喹啉组和辛醇组给药前后大鼠行为学评分比较差异有统计学意义(P<0.01);而生理盐水组差异无统计学意义(P>0.05)。喹啉组和辛醇组大鼠海马神经元Cx36的表达明显低于生理盐水组(P<0.01),但2组Cx36的表达量差异无统计学意义(P>0.05)。结论 Cx36在癫发作中起着重要作用,可能成为潜在的治疗靶点。 Objective To observe the expression of connexin 36(Cx36) in status epilepticus in hippocampal neurons. Methods Thirty-six experimental status epilepticus rats induced by lithium chloride-pilocarpine were randomly divided into control group,quinine group,octanol group.Quinine,octanol and saline was administered in vivo.The Racine score was used to decide epileptic seizure before and after administering drug respectively.The expression of Cx36 in hippocampal neurons in each group was determined by using immunofluorescentstaining and Western blotting. Results The Racine score has significant difference before and after administering drug in quinine group and octanol group individually(P0.01).However,there was no significant difference in saline group(P0.05).The expression of Cx36 in hippocampal neurons was lower in quinine group and in octanol group than that in control group.However,there was no significant difference in quinine group and octanol group(P0.05). Conclusion The Cx36 gap junction in neuron may play critical role in seizure activity and may be a potential therapeutic target in epilepsy.
出处 《中国实用神经疾病杂志》 2012年第7期4-6,共3页 Chinese Journal of Practical Nervous Diseases
关键词 癫持续状态 Cx36 匹罗卡品 喹啉 辛醇 Status epilepticus Cx36 Pilocarpin Quinine Octanol
  • 相关文献

参考文献11

  • 1彭建伟,黄怀均.癫痫药物的治疗进展[J].河南实用神经疾病杂志,2001,4(3):88-89. 被引量:1
  • 2Fukuda T.Gap junctions among dendrites of cortical GABAergic neurons establish a dense and widespread intercolumnar net-work[J].Neurosci,2006,26(13):3434-3443.
  • 3Rash JE.Identification of cells expressing Cx43,Cx30,Cx26,Cx32and Cx36in gap junctions of rat brain and spinal cord[J].Cell Commun Adhes,2001,8(4):315-320.
  • 4Glien M.Repeated low-dose treatment of rats with pilocar-pine:low mortality but high proportion of rats developing epi-lepsy[J].Epilepsy Res,2001,46(2):111-119.
  • 5Racine RJ.Modification of seizure activity by electrical stimu-lation.Ⅱ.Motor seizure[J].Electroencephalogr Clin Neuro-physiol,1972,32(3):281-294.
  • 6Condorelli DF.Cloning of a new gap junction gene(Cx36)highly expressed in mammalian brain neurons[J].Eur J Neu-rosci,1998,10(3):1202-1208.
  • 7Condorelli DF.Expression of Cx36in mammalian neurons[J].Brain Res Brain Res Rev,2000,32(1):72-85.
  • 8Medina-Ceja L,Ventura-Mejía C.Differential effects of trime-thylamine and quinine on seizures induced by4-aminopyridine administration in the entorhinal cortex of vigilant rats[J].Sei-zure,2010,19(8):507-513.
  • 9Gajda Z.Involvement of gap junctions in the manifestation and control of the duration of seizures in rats in vivo[J].Epilepsia,2003,44(12):1596-1600.
  • 10Beheshti S.Changes in hippocampal connexin36mRNA and protein levels during epileptogenesis in the kindling model of epilepsy[J].Prog Neuropsychopharmacol Biol Psychiatry,2010,34(3):510-515.

二级参考文献10

  • 1[1]Pennell PB, Ogaily MS, Maedonald RL. Aplastic anemia in a patient receiving feibamatc for complex partial seizurcs. Neurology, 1995, 45:456~460
  • 2[2]Applcton R, Fichtncr K, Lamourcaux Lc al. Gabapcntin as add- on therapy in children with refractory partial seizncs: a 12 - cc multiccntcr, doublc -blind, placcbo- controlled study, Gabapentin paediatric study group,Epilepsia 1999, 40 (8): 1147~ 1154
  • 3[3]Duchowny M, Pellock JM, Graf WD, et al. Larmotrigine add- on therapy for partial seizures in children. Neurology, 1999, 53:1724
  • 4[4]Petroff O. AC, Hydor F, Mattson R H, et al. topiramate increases brain GABA, homocamosine and pyrrolidinone in patients with epilepsy. Neurology, 1999, 52:473
  • 5[5]Hanny A, Litzinger MJ. Tiagabine add- on treatment improves neurobehavioral and cpilcpst- related symtoms in pediatric seizures patients (abstract),epilepsia, 1999; 40 (suppl7): 132
  • 6[6]pcruccaE, the clinical pharmacokinctics of the new antiepileptic drugs,epilepsia, 1999, 40 (supplc 19): S7~13
  • 7[7]Grant SM, Hccl RC. Vigbatrin: areview of it's pharmacodynamic and pharmacokinetic properties and theraputic potential in epilepsy and disorders of motor control, drugs, 1991, 4166): 889 ~ 926
  • 8[8]Schachter SC, VazguczB, fishcr RS, ctal. Oxcarbazcpinc: doublcblind, randomized, placebo- control, monotherapy trial for partial seizures, Neurology, 1999, 52:732~737
  • 9[9]CereghinoJJ, BitonV, Abou-khalilB, etal. results of a double - blind,randomized clinical trial, Neurology, 20000, 55:236~242
  • 10[10]Percca E. The spectrum of the new antiepileptic drugs, Acta. Neurol.Belg, 1999, 99 (4): 231 ~ 238

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部